Global Assets Advisory »

Arrowhead Pharmaceuticals shares owned by Global Assets Advisory

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Global Assets Advisory from 13F filings

Historical chart of Global Assets Advisory investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Global Assets Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Global Assets Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 40k 35.41

More positions owned by Global Assets Advisory

Exxon Mobil Corporation (XOM)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Pfd And Incm Sec (PFF)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
First Tr Exchng Traded Fd Vi Skybridge Crypto (CRPT)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Amazon (AMZN)
C3 Ai Cl A (AI)
Verizon Communications (VZ)

View all positions for Global Assets Advisory

Top funds holding Arrowhead Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Credit Suisse
Norges Bank Investment Management
Rokos Capital Management
Artal Group
venBio Select Advisor
Goldman Sachs Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Aquilo Capital Management
Charles Schwab Investment Management
Western Financial Corp
Avidity Partners Management
E. Ohman J:or Asset Management AB

View all funds holding Arrowhead Pharmaceuticals